255 related articles for article (PubMed ID: 25315705)
21. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
[TBL] [Abstract][Full Text] [Related]
22. Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.
Starska K; Forma E; Jóźwiak P; Lewy-Trenda I; Danilewicz M; Stasikowska-Kanicka O; Skóra M; Kolary K; Miazga J; Krześlak A; Bryś M
Tumour Biol; 2016 Oct; 37(10):13185-13203. PubMed ID: 27456359
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of a missense mutation in the
Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
[No Abstract] [Full Text] [Related]
24. O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.
Jin L; Lu MH; Dai GC; Yao Q; Xiang H; Wang LX; Xue BX; Liu X
Neoplasma; 2020 Jul; 67(4):880-888. PubMed ID: 32305058
[TBL] [Abstract][Full Text] [Related]
25. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
[TBL] [Abstract][Full Text] [Related]
26. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
27. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
Stephen HM; Adams TM; Wells L
Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
[TBL] [Abstract][Full Text] [Related]
28. O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth.
Singh JP; Qian K; Lee JS; Zhou J; Han X; Zhang B; Ong Q; Ni W; Jiang M; Ruan HB; Li MD; Zhang K; Ding Z; Lee P; Singh K; Wu J; Herzog RI; Kaech S; Wendel HG; Yates JR; Han W; Sherwin RS; Nie Y; Yang X
Oncogene; 2020 Jan; 39(3):560-573. PubMed ID: 31501520
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
[TBL] [Abstract][Full Text] [Related]
30. O-GlcNAcylation regulates extracellular signal-regulated kinase (ERK) activation in Alzheimer's disease.
Ephrame SJ; Cork GK; Marshall V; Johnston MA; Shawa J; Alghusen I; Qiang A; Denson AR; Carman MS; Fedosyuk H; Swerdlow RH; Slawson C
Front Aging Neurosci; 2023; 15():1155630. PubMed ID: 37469955
[TBL] [Abstract][Full Text] [Related]
31. O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.
Webster DM; Teo CF; Sun Y; Wloga D; Gay S; Klonowski KD; Wells L; Dougan ST
BMC Dev Biol; 2009 Apr; 9():28. PubMed ID: 19383152
[TBL] [Abstract][Full Text] [Related]
32. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
33. Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations.
Krześlak A; Wójcik-Krowiranda K; Forma E; Bieńkiewicz A; Bryś M
Ginekol Pol; 2012 Jan; 83(1):22-6. PubMed ID: 22384635
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer.
Hu CW; Xie J; Jiang J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291918
[TBL] [Abstract][Full Text] [Related]
35. Excessive
Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
[TBL] [Abstract][Full Text] [Related]
36. O-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.
Zhang Z; Costa FC; Tan EP; Bushue N; DiTacchio L; Costello CE; McComb ME; Whelan SA; Peterson KR; Slawson C
J Biol Chem; 2016 Jul; 291(30):15628-40. PubMed ID: 27231347
[TBL] [Abstract][Full Text] [Related]
37. Nanomolar inhibition of human OGA by 2-acetamido-2-deoxy-d-glucono-1,5-lactone semicarbazone derivatives.
Kiss M; Szabó E; Bocska B; Sinh LT; Fernandes CP; Timári I; Hayes JM; Somsák L; Barna T
Eur J Med Chem; 2021 Nov; 223():113649. PubMed ID: 34186233
[TBL] [Abstract][Full Text] [Related]
38. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
Nagel AK; Ball LE
Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
[TBL] [Abstract][Full Text] [Related]
39. A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis.
Park SK; Zhou X; Pendleton KE; Hunter OV; Kohler JJ; O'Donnell KA; Conrad NK
Cell Rep; 2017 Aug; 20(5):1088-1099. PubMed ID: 28768194
[TBL] [Abstract][Full Text] [Related]
40. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
